Manling Du

524 total citations
10 papers, 409 citations indexed

About

Manling Du is a scholar working on Biomaterials, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Manling Du has authored 10 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biomaterials, 3 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Manling Du's work include Nanoparticle-Based Drug Delivery (4 papers), Cancer therapeutics and mechanisms (2 papers) and Cholesterol and Lipid Metabolism (1 paper). Manling Du is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Cancer therapeutics and mechanisms (2 papers) and Cholesterol and Lipid Metabolism (1 paper). Manling Du collaborates with scholars based in China, India and Australia. Manling Du's co-authors include Tiange Cai, Yu Cai, Fansu Meng, Yong Zhuang, Hui Liu, Qianqian Ma, Lianyu Chen, Zhen Chen, Yinghong Huang and Qi Wang and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Ethnopharmacology and International Journal of Nanomedicine.

In The Last Decade

Manling Du

10 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manling Du China 8 217 111 109 37 29 10 409
Maliheh Parsa Iran 13 209 1.0× 125 1.1× 110 1.0× 32 0.9× 32 1.1× 19 574
Awaji Y. Safhi Saudi Arabia 12 162 0.7× 143 1.3× 124 1.1× 30 0.8× 49 1.7× 45 590
Ling-Chun Chen Taiwan 14 189 0.9× 165 1.5× 98 0.9× 30 0.8× 70 2.4× 22 606
Zhaowen Liu China 13 118 0.5× 127 1.1× 92 0.8× 36 1.0× 29 1.0× 34 470
Akansha Bisht India 11 130 0.6× 108 1.0× 101 0.9× 29 0.8× 31 1.1× 19 475
Ana Isabel Barbosa Portugal 9 139 0.6× 67 0.6× 79 0.7× 42 1.1× 77 2.7× 16 513
Le Hang Dang Vietnam 13 263 1.2× 93 0.8× 144 1.3× 49 1.3× 45 1.6× 36 587
Juhi Singh India 11 122 0.6× 46 0.4× 53 0.5× 26 0.7× 32 1.1× 36 425
Naveed Ullah Khan China 14 249 1.1× 120 1.1× 182 1.7× 17 0.5× 24 0.8× 30 545

Countries citing papers authored by Manling Du

Since Specialization
Citations

This map shows the geographic impact of Manling Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manling Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manling Du more than expected).

Fields of papers citing papers by Manling Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manling Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manling Du. The network helps show where Manling Du may publish in the future.

Co-authorship network of co-authors of Manling Du

This figure shows the co-authorship network connecting the top 25 collaborators of Manling Du. A scholar is included among the top collaborators of Manling Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manling Du. Manling Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ouyang, Yong, Fansu Meng, Manling Du, et al.. (2022). Protective effects of psoralen polymer lipid nanoparticles on doxorubicin - induced myocardial toxicity. Brazilian Journal of Pharmaceutical Sciences. 58. 1 indexed citations
2.
Ma, Qianqian, Min Liang, Tiange Cai, et al.. (2020). Protective Effect of Shenqi Maixintong Capsule against ox‐LDL‐Induced Injury in RAW264.7 Macrophages. Evidence-based Complementary and Alternative Medicine. 2020(1). 1 indexed citations
3.
Du, Manling, Zhenjiang Yang, Wenping Lü, et al.. (2020). Design and development of spirulina polysaccharide-loaded nanoemulsions with improved the antitumor effects of paclitaxel. Journal of Microencapsulation. 37(6). 403–412. 22 indexed citations
4.
Ma, Qianqian, Fansu Meng, Malleshappa N. Noolvi, et al.. (2019). A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis. Journal of Ethnopharmacology. 244. 112105–112105. 35 indexed citations
5.
Du, Manling, Yong Ouyang, Fansu Meng, et al.. (2019). Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer. International Journal of Pharmaceutics. 561. 274–282. 49 indexed citations
6.
Cai, Tiange, Richard Callaghan, Qianwen Li, et al.. (2019). <p>Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells</p>. International Journal of Nanomedicine. Volume 14. 2207–2218. 22 indexed citations
7.
Huang, Yinghong, Fansu Meng, Yong Zhuang, et al.. (2019). Application of bacterial cellulose in skin and bone tissue engineering. European Polymer Journal. 122. 109365–109365. 174 indexed citations
8.
Du, Manling, Yong Ouyang, Fansu Meng, et al.. (2019). Nanotargeted Agents: An Emerging Therapeutic Strategy for Breast Cancer. Nanomedicine. 14(13). 1771–1786. 43 indexed citations
9.
Liu, Qian, et al.. (2018). Extraction of Polysaccharide from Spirulina and Evaluation of Its Activities. Evidence-based Complementary and Alternative Medicine. 2018(1). 3425615–3425615. 45 indexed citations
10.
Cai, Tiange, Qian Liu, John C. Whitney, et al.. (2018). Preparation and evaluation of spirulina polysaccharide nanoemulsions. International Journal of Molecular Medicine. 42(3). 1273–1282. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026